-
effectivehealthcare.ahrq.gov/sites/default/files/interventions-horizon-scan-high-impact-1306.pdf
June 01, 2013 - AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Crosscutting Interventions and Programs
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
Contract No. HHS…
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
January 01, 2012 - Diabetes Mellitus
AHRQ Healthcare Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 07: Diabetes Mellitus
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Combination Therapy Versus Intensification of Statin Monotherapy:
An Update.
Draft revi…
-
effectivehealthcare.ahrq.gov/health-topics/cancer-immunotherapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
September 01, 2012 - a
program of individualized training sessions and decision support tools to aid LTC nurses with
symptom
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2320
Published Online: October 12, 2016
Evidence Report/Technology Assessment Disposition of Comments Report
R…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
April 01, 2012 - 1
Comparative Effectiveness Review
Number 60
Treatment for Glaucoma:
Comparative Effectiveness
Executive Summary
Background
Glaucoma is a leading cause of visual
impairment and blindness both in the
United States and worldwide. It is
estimated to affect 60.5 million people
worldwide.1 Glaucoma is defined as…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-strength-evidence.ppt
June 01, 2012 - PowerPoint Presentation
Grading the Strength of a Body of Evidence on Diagnostic Tests
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Grading the Strength of a Body of Evidence on Diagnostic Tests
This slide set is based on c…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
September 01, 2011 - Layout 1
Background
Antipsychotics medications are approved
by the U.S. Food and Drug Administration
(FDA) for treatment of schizophrenia and
bipolar disorder. These medications are
commonly divided into two classes,
reflecting two waves of historical
development: the conventional
antipsychotics and the atypical. T…
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - Diabetes Mellitus
AHRQ Healthcare Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 07: Diabetes Mellitus
Potential High Impact Interventions Report
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaithe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
January 01, 2014 - 1
Comparative Effectiveness Review
Number 127
Chronic Venous Ulcers: A Comparative
Effectiveness Review of Treatment Modalities
Executive Summary
Background
Venous leg ulcers are extremely common
in the United States. They affect between
500,000 and 2 million people annually, and
are responsible for over 50 pe…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
March 01, 2012 - Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions
Methods Guide
for Comparative Effectiveness Reviews
Assessing the Risk of Bias of Individual Studies
in Systematic Reviews of Health Care Interventions
Comparative Effectiveness Reviews are syste…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_executive.pdf
December 01, 2014 - 1
Radiotherapy Treatments for Head and Neck
Cancer Update
Executive Summary
Introduction
Objectives
In May 2010, the Agency for Healthcare
Research and Quality (AHRQ) published
the results of Comparative Effectiveness
Review (CER) No. 20, “Comparative
Effectiveness and Safety of Radiotherapy
Treatments for H…
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-strength-evidence.ppt
June 01, 2012 - PowerPoint Presentation
Grading the Strength of a Body of Evidence on Diagnostic Tests
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Grading the Strength of a Body of Evidence on Diagnostic Tests
This slide set is based on c…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
September 11, 2015 - Behavioral Programs for Diabetes Mellitus
Evidence-Based
Practice
Evidence-based Practice
Program
The Agency for Healthcare Research and
Quality (AHRQ), through its Evidence-
based Practice Centers (EPCs), sponsors
the development of evidence reports and
technology assessments to assist public-
and private-s…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2417
Published Online: March 24, 2017
Comparative Effect…
-
effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
March 24, 2017 - Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2417
Published Online: March 24, 2017
Comparative Effect…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
August 01, 2013 - 1
Comparative Effectiveness Review
Number 123
Stroke Prevention in Atrial Fibrillation
Executive Summary
Background
Atrial Fibrillation and Stroke
Atrial fibrillation (AF) is a common type
of supraventricular tachyarrhythmia. While
a supraventricular tachyarrhythmia is a
tachycardic rhythm originating above t…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…